The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pooled analysis of the secondary resection for colorectal cancer liver metastases: Comparison of bevacizumab (Bmab) and anti-EGFRs.
 
Wataru Ichikawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Nippon Kayaku; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Merck Serono; Ono Pharmaceutical; Zeria Pharmaceutical
Research Funding - Eisai; Taiho Pharmaceutical; Takeda
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Yu Sunakawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hirofumi Nakayama
No Relationships to Disclose
 
Toshikazu Ikusue
No Relationships to Disclose
 
Toshikado Kaneta
No Relationships to Disclose
 
Hiromi Imataka
No Relationships to Disclose
 
Takashi Sekikawa
No Relationships to Disclose
 
Yasutsuna Sasaki
Honoraria - Eisai; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Boehringer Ingelheim; Chugai Pharma; Eisai; Kyowa Hakko Kirin; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical